These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27728876)

  • 1. A pharmacological mouse model suggests a novel risk pathway for postpartum psychosis.
    Humby T; Cross ES; Messer L; Guerrero S; Davies W
    Psychoneuroendocrinology; 2016 Dec; 74():363-370. PubMed ID: 27728876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do Defective Immune System-Mediated Myelination Processes Increase Postpartum Psychosis Risk?
    Dazzan P; Fusté M; Davies W
    Trends Mol Med; 2018 Nov; 24(11):942-949. PubMed ID: 30348609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The steroid sulfatase inhibitor COUMATE attenuates rather than enhances access of dehydroepiandrosterone sulfate to the brain in the mouse.
    Nicolas LB; Fry JP
    Brain Res; 2007 Oct; 1174():92-6. PubMed ID: 17868658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Converging pharmacological and genetic evidence indicates a role for steroid sulfatase in attention.
    Davies W; Humby T; Kong W; Otter T; Burgoyne PS; Wilkinson LS
    Biol Psychiatry; 2009 Aug; 66(4):360-7. PubMed ID: 19251250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does steroid sulfatase deficiency influence postpartum psychosis risk?
    Davies W
    Trends Mol Med; 2012 May; 18(5):256-62. PubMed ID: 22475435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice.
    Nicolas LB; Pinoteau W; Papot S; Routier S; Guillaumet G; Mortaud S
    Brain Res; 2001 Dec; 922(2):216-22. PubMed ID: 11743952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and pharmacological modulation of the steroid sulfatase axis improves response control; comparison with drugs used in ADHD.
    Davies W; Humby T; Trent S; Eddy JB; Ojarikre OA; Wilkinson LS
    Neuropsychopharmacology; 2014 Oct; 39(11):2622-32. PubMed ID: 24842408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo activity of 4-methylcoumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor.
    Purohit A; Woo LW; Singh A; Winterborn CJ; Potter BV; Reed MJ
    Cancer Res; 1996 Nov; 56(21):4950-5. PubMed ID: 8895749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
    Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV
    J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid sulfatase-deficient mice exhibit endophenotypes relevant to attention deficit hyperactivity disorder.
    Trent S; Dennehy A; Richardson H; Ojarikre OA; Burgoyne PS; Humby T; Davies W
    Psychoneuroendocrinology; 2012 Feb; 37(2):221-9. PubMed ID: 21723668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of steroid sulfatase activity in endometriotic implants by STX64 (667Coumate): a potential new therapy.
    Fusi L; Purohit A; Brosens J; Woo LW; Potter BV; Reed MJ
    ScientificWorldJournal; 2008 Dec; 8():1325-7. PubMed ID: 19112542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Gene Expression in a Novel Mouse Model of Postpartum Mood Disorder.
    Humby T; Davies W
    Transl Neurosci; 2019; 10():168-174. PubMed ID: 31410299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models.
    Ishida H; Nakata T; Suzuki M; Shiotsu Y; Tanaka H; Sato N; Terasaki Y; Takebayashi M; Anazawa H; Murakata C; Li PK; Kuwabara T; Akinaga S
    Breast Cancer Res Treat; 2007 Dec; 106(2):215-27. PubMed ID: 17268815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo.
    Ishida H; Nakata T; Sato N; Li PK; Kuwabara T; Akinaga S
    Breast Cancer Res Treat; 2007 Aug; 104(2):211-9. PubMed ID: 17061037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel steroid sulfatase inhibitors based on N-thiophosphorylated 3-(4-aminophenyl)-coumarin-7-O-sulfamates.
    Daśko M; Demkowicz S; Biernacki K; Harrous A; Rachon J; Kozak W; Martyna A; Masłyk M; Kubiński K; Boguszewska-Czubara A
    Drug Dev Res; 2019 Sep; 80(6):857-866. PubMed ID: 31301181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Analysis of Cellular Communication Network Factor Proteins as Candidate Mediators of Postpartum Psychosis Risk.
    Davies W
    Front Psychiatry; 2019; 10():876. PubMed ID: 31849729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid sulfatase: molecular biology, regulation, and inhibition.
    Reed MJ; Purohit A; Woo LW; Newman SP; Potter BV
    Endocr Rev; 2005 Apr; 26(2):171-202. PubMed ID: 15561802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spotlight on ziprasidone in schizophrenia and schizoaffective disorder.
    Gunasekara NS; Spencer CM; Keating GM
    CNS Drugs; 2002; 16(9):645-52. PubMed ID: 12153335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton-in-flight mechanism for the spontaneous hydrolysis of N-methyl O-phenyl sulfamate: implications for the design of steroid sulfatase inhibitors.
    Edwards DR; Wolfenden R
    J Org Chem; 2012 May; 77(9):4450-3. PubMed ID: 22486328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor.
    Stanway SJ; Purohit A; Woo LW; Sufi S; Vigushin D; Ward R; Wilson RH; Stanczyk FZ; Dobbs N; Kulinskaya E; Elliott M; Potter BV; Reed MJ; Coombes RC
    Clin Cancer Res; 2006 Mar; 12(5):1585-92. PubMed ID: 16533785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.